MENU
CASI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CASI Pharmaceuticals (CASI) Ownership - Who owns CASI Pharmaceuticals?
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
No. 81, Jianguo Road
Phone
+86 01065618789
Employees
243
Web
https://www.casipharmaceuticals.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.97M
P/E Ratio
N/A
Total Cash
20.81M
Projected Growth
N/A
Total Debt
19.12M
Revenue
22.06M
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash/Share
1.34
Total Debt/Equity
N/A
Revenue/Share
1.98 USD as % of share price
Fundamentals
CASI
Capitalization
29M
P/E Ratio
N/A
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash
20.8M
Total Cash/Share
1.34
Total Debt
19.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.98%
Revenue
22.1M
ROE
N/A
Book Value
13.8M
P/B Ratio
15.97
Cash Flow
N/A
Earnings
-2.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
3.20
Current Revenue Per Employee
32069.96
Dividends Per Share - Security
N/A
EBITDA
-31.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
51.91
Revenue To Assets
-44.93
Shares Held By Institutions
7.57M
Shares Outstanding - Current
15.5M
Total Liabilities
49.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-33.919
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical drugs for treating cancer and inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
No. 81, Jianguo Road
Phone
+86 01065618789
Employees
243
Web
https://www.casipharmaceuticals.com